Increased release of striatal dopamine after long-term treatment with methadone in rats: inhibition by agents which increase central 5-hydroxytryptamine transmission.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000031:analogs & derivatives / Q000378:metabolism*; D005277:Fenfluramine / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D008297:Male; D008691:Methadone / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects*
D010879:Piperazines; D015102:3,4-Dihydroxyphenylacetic Acid; D005277:Fenfluramine; D012701:Serotonin; C001746:3-methoxytyramine; C015068:1-(3-chlorophenyl)piperazine; D008691:Methadone; D004298:Dopamine; D006719:Homovanillic Acid